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Abstract 
Predominance of beneficial bacteria helps to establish a healthy microbiota in fish gastrointestinal system and thus to reduce 
emerging pathogen. In this study, the colonization efficacy of Lactococcus lactis subsp. lactis CF4MRS in Artemia franciscana 
and its potential as a probiotic in suppressing Edwardsiella sp. infection were investigated in vivo. The colonization extent of the 
bioencapsulated L. lactis was established through visualization of gfp gene-transformed L. lactis in A. franciscana. Here, we 
demonstrate that when A. franciscana is administrated with L. lactis at 108 CFU mL−1 for 8 h, the highest relative percentage of 
survival (RPS = 50.0) is observed after inoculation with Edwardsiella sp. The total counts of L. lactis entrapped in Artemia were 
the highest (ranged from 3.2 to 5.1 × 108 CFU mL−1), when 108–109 CFU mL−1 of L. lactis was used as starting inoculum, with 
the bioencapsulation performed within 8–24 h. Fluorescent microscopy showed gfp-transformed L. lactis colonized the external 
trunk surfaces, mid-gut and locomotion antennules of the A. franciscana nauplii. These illustrations elucidate the efficiency of 
colonization of L. lactis in the gastrointestinal tract and on the body surfaces of Artemia. In conclusion, L. lactis subsp. lactis 
CF4MRS shows a good efficacy of colonization in Artemia and has the potential for biocontrol/probiotic activity against 
Edwardsiella sp. infection. 
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Introduction 
 
Aquaculture is the fastest growing food industry (Saravanan 
et al. 2013). However, the rapid expansion of the industry has 
resulted in massive occurrence of various fish diseases. 
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Aquaculture of fish, in particularly, turbot Scophthalmus 
maximus, Japanese flounder Paralichthys olivaceus, Nile tila- 
pia Oreochromis niloticus and catfish Clarias batrachus, of- 
ten develop diseases such as edwardsiellosis (Sahoo et al. 
1998; Kim et al. 2003; Zheng et al. 2004; Padros et al. 
2006). The Gram-negative pathogen Edwardsiella sp. is the 
major cause of edwardsiellosis, which can cause hemorrhagic 
septicemia including lesions on the skin, muscles and internal 
organs in many aquatic species (Bullock and Herman 1985; 
Mohanty and Sahoo 2007). The spread of Edwardsiella sp. 
in fish culture systems can be transmitted via contaminated 
equipment and facilities used in cultivation, or during the 
harvesting process of the live feed (Mainous et al. 2010). 
Common live feed include Artemia and rotifers and are 
often used as natural food sources for post-larvae in finfish 
or shrimp hatchery. Studies showed that Artemia could be a 
potential bio-vehicle for the transmission of several fish 
diseases; evidence indicates these live feeds can be in- 
volved (directly or indirectly) in transmitting piscine cryp- 
tosporidiosis infection caused by Cryptosporidium molnari 
and Cryptosporidium scophthalmi (Méndez-Hermida et al. 
  
 
2007). Sivakumar et al. (2009) claimed that Artemia might 
be a possible horizontal transmission pathway for 
Hepatopancreatic parvo-like virus (HPV) in post-larvae 
of Penaeus monodon (Sivakumar et al. 2009). More im- 
portantly, a recent study demonstrated E. tarda and 
E. ictaluri can be transmitted via the oral route, particularly 
when pathogen-infected Artemia was used asa food source 
for Nile tilapia Oreochromis niloticus larvae (Situmorang 
et al. 2014). To control edwardsiellosis, conventional che- 
motherapeutic approaches are carried out, including pre- 
disinfection of the facility and application of prophylactic 
antibiotics for preventative measures or treatment pur- 
poses. However, the excessive use of antibiotics raises 
many food safety concerns; therefore, probiotics would 
be an advantageous alternative to control Edwardsiella 
sp. infections. 
Probiotics are defined as live microorganisms which, 
when administrated in adequate amounts, confer health ben- 
efits to the host (FAO and WHO 2001). In most cases, 
probiotics are supplied as live supplements in feed complex, 
which can then benefit the fish and shrimp through inhibi- 
tion of pathogenic microbes, improving immune response, 
improving survival and growth rates, increasing feed utili- 
zation, enhancing digestion and promoting antimutagenic 
or anticarcinogenic activity, and furthermore, some species 
have been suggested for improvement of water quality in 
aquaculture systems (Harikrishnan et al. 2010; Andani et al. 
2012). In hatchery production, probiotics are generally ap- 
plied through the oral route through live feed (e.g. Artemia 
and rotifers) (Hai et al. 2010). Probiotics could help to pre- 
vent bacterial infections by preventing the colonization of 
pathogenic bacteria (Villamil et al. 2010). Effective 
probiotics used in the fish industry possess several charac- 
teristics, including antimicrobial properties, adhesion 
capacity and growth on the intestinal or external mucous 
of the fish, are also relatively important to determine the 
feasibility of the putative probiotic in the field. Chang and 
Liu (2002) reported only certain bacterial species that colo- 
nized the GI tract could exert the protection to the eel 
Anguilla anguilla L. from edwardsiellosis infection. Thus, 
probiotic colonization in the GI (gastrointestinal) tract 
should be of particular importance to determine the viability 
and functionality of the beneficial bacteria. 
In the present study, a potential probiotic strain, 
Lactococcus lactis subsp. lactis (CF4MRS), previously 
isolated from farmed fish (Loh et al.  2014;  Loh  and  
Ting 2016) was used to evaluate for inhibitory effect 
against Edwardsiella sp.  using  A.  franciscana as  a host 
in an in vivo pathogenic assays. The bacterial uptake, 
proliferation and colonization were determined through  
the employment of gfp-transformed L. lactis in the live 
feed. Efficacy of the bioencapsulation process and the 
probiotic dosage were also optimized in this study. 
Materials and Methods 
 
Bacterial Culture of Lactococcus lactis subsp. lactis 
 
The bacterium Lactococcus lactis subsp. lactis CF4MRS 
(GenBank accession number: KM488626) was previously 
isolated from the GI tract of farmed freshwater catfish, 
Clarias batrachus (Monash University Animal Ethics 
Committee approval no.: MARP/2012/117) (Loh et al. 
2014). The strain CF4MRS was sub-cultured regularly on de 
Man Rogosa and Sharp agar (MRS, Difco™, BD, USA). For 
the bioencapsulation experiment, the cell density of L. lactis in 
MRS broth (overnight culture) was adjusted to 106, 107, 108 
and 109 CFU mL−1 (OD540) using 10 g L−1 autoclaved artifi- 
cial seawater (pH 7.5) (Instant Ocean® Sea Salt, USA). For 
the in vivo assay, the pathogenic Edwardsiella sp. BCRC 
16703 (98% similarity to E. anguillarum, see supplementary 
BCRC 16703 gene sequences) (http://www.bcrc.firdi.org.tw) 
was adjusted to 105 CFU mL−1 using sterile artificial seawater. 
 
Artemia Nauplii Hatching and Pre-disinfection 
 
The cysts of Artemia franciscana (Great Lake Artemia, Salt 
Lake City, UT, USA) were exposed to UV radiation (254 nm) 
for pre-disinfection in a laminar flow hood for 30 min prior to 
hatching. The cysts (6 g L−1) were placed in a 500-mL 
Artemio® set (JBL, Neuhofen, Germany) connected to an 
aerator and filled with sterile artificial seawater (20 g L−1, 
pH 7.5). Artemia cysts were incubated under continuous aer- 
ation at 26 ± 2 °C for 20–24 h. (Touraki et al. 2013) and a 
photoperiod of 12:12 h (light:dark). The newly hatched 
nauplii (instar I) were collected, starved for 6 h and subse- 
quently surface-disinfected with 10 ml L−1 Ovadine® (10% 
povidone-iodine) (Syndel Laboratories Ltd., Canada) for 
10 min. The disinfected Artemia nauplii were then used for 
the in vivo pathogenic study. 
 
In Vivo Challenge of Artemia Nauplii 
with Edwardsiella sp. 
 
The surface-disinfected Artemia nauplii (Instar II, at approx. 
28 h) were transferred into 250-mL conical flasks with a den- 
sity of approx. 300 individuals per milliliter. This experiment 
consisted of seven treatments: positive control (nauplii with 
no Lactococcus lactis subsp. lactis were administered but 
challenged with Edwardsiella sp.), the negative control 
(nauplii were administrated with 106 CFU mL−1 L. lactis but 
without challenged with Edwardsiella sp.), blank treatment 
(nauplii with no L. lactis administration and without chal- 
lenged with Edwardsiella sp.) and four different treatments 
of nauplii, each of which were administrated with 106, 107, 
108 and 109 CFU mL−1 L. lactis and subsequently challenged 
with Edwardsiella sp. 
  
 
Artemia nauplii were exposed to L. lactis for 1, 4, 8, 12 and 
24 h. After bioencapsulation, a total of 20 Artemia nauplii per 
replicate were transferred aseptically from the flasks into 55- 
mm (in diameter) sterile Petri dishes, containing 10 mL of 
Edwardsiella sp. at 105 CFU mL−1 (except in the negative 
and blank treatments whereby Edwardsiella sp. was exclud- 
ed). After 48 h of incubation, the Edwardsiella sp. suspen- 
sions were replaced with fresh suspensions at the same con- 
centrations. A food source of autoclaved yeast Saccharomyces 
cerevisiae (Mauri-pan® instant yeast, Malaysia) (5.6 × 107 
cells mL−1 in 10 g L−1 sterile artificial seawater, pH 7.5) was 
administered to the Artemia nauplii daily (100 μL dish−1) 
throughout the experiment (Marques et al. 2004). Each treat- 
ment was performed in triplicate. The survival rates of the 
nauplii were monitored and recorded throughout the experi- 
ment until a complete mortality (100%) was achieved in the 
positive control. The relative percentage of survival (RPS) 
was calculated based on the following formula (Amend 1981): 
RPS ð%Þ ¼ 1−ðM t=M cÞ × 100 
where Mt is mortality from treatment and Mc mortality from 
control. RPS values (equivalent to ED50) ≥ 50 indicated a 
positive effect (Cunningham et al. 2010) of L. lactis against 
the pathogen Edwardsiella sp. 
In addition, water quality was monitored throughout the 
experiment period for dissolved oxygen (DO), pH, tempera- 
ture, total dissolved solid (TDS), salinity and total ammonia 
contents (Table 1). The DO, pH, temperature, TDS and salin- 
ity were determined using an Eutech instrument (PCD 650, 
Thermo Fisher Scientific, Singapore), while total ammonia 
nitrogen (NH3-N), nitrite nitrogen (NO2-N) and nitrate nitro- 
gen (NO3-N) were measured using a Hach colorimeter 
(DR890, Hach, USA) according to the Standard Methods for 
the Examination of Water and Wastewater (APHA 1985). 
 
Optimization of Bioencapsulation 
 
Firstly, new batches of Artemia nauplii were surface- 
disinfected using Ovadine® and then rinsed thoroughly with 
autoclaved artificial seawater. Nauplii (approx. 300 nauplii 
mL−1) were transferred to 250-mL conical flasks containing 
100 mL bacterial suspensions of various concentrations (106, 
107, 108 and 109 CFU mL−1 in autoclaved artificial seawater). 
Artemia nauplii without treatment with L. lactis were used as 
the control. Mild aeration (filtered through 0.22-μm mem- 
brane filters) was provided at the bottom of the flasks to ensure 
sufficient oxygenation in the Artemia culture. 
To quantify the total number of L. lactis cells 
bioencapsulated in the nauplii, 1 mL of Artemia nauplii of each 
treatment was collected after 1, 4, 8, 12 and 24 h of 
bioencapsulation. All nauplii were washed (5 mL sterile saline 
solution, NaCl, 0.85% w/v) and collected through sterile 
microclothes (Calbiochem, Merck, Germany). The nauplii were 
then transferred to 2 mL sterile saline solutions and macerated 
using a homogenizer (LabGEN®125, Cole-Parmar, USA). 
Serial dilutions of the homogenized suspensions were made 
down to 10−9, plated (100 μL) on nutrient agar (Badhul Haq  et 
al. 2012) and incubated at 26 ± 2 °C for 24–48 h. CFU were 
counted to enumerate the viable bacteria that were successfully 
encapsulated in the Artemia nauplii (all quantification experi- 
ments were done in triplicate). 
 
Colonization of gfp-Transformed L. lactis 
in A. franciscana 
 
Colonization and proliferation of Lactococcus lactis subsp. 
lactis CF4MRS in Artemia franciscana were detected via 
green fluorescent protein (GFP) (Fernández de  Palencia 
et al. 2000). The gfp-transformation process was firstly initi- 
ated by culturing the lactococcal cells (CF4MRS) in GM17 
medium (M17 broth (Oxoid Ltd., Hampshire, UK) supple- 
mented with 1% glucose) at 37 °C overnight. Cultures were 
diluted 100-fold in SGM17 medium (GM17 supplemented 
with 0.5 M sucrose) containing 3% glycine (Vivantis 
Technologies Sdn Bhd., Malaysia) (Holo and Nes 1989). 
Exponential-phase cells were grown to 0.2–0.7 cell densities 
(OD600) at 30 °C. The lactococcal cells were harvested by 
centrifugation at 6000×g for 5 min at 4 °C and washed fol- 
lowing the protocol suggested by Dornan and Collins (1990). 
The lactococcal cells were re-suspended in 2 mL of 0.22 μm 
filtered Milli-Q water (Merck Millipore, USA), the cells were 
collected by centrifugation (6000×g for 5 min at 4 °C) and the 
supernatant was discarded. A second wash in 1 mL of 
 
 
Table 1 Water quality in the A. franciscana experimental flasks 
Water quality physicochemical parameters 
 
 
DO 
(mg L−1) 
pH Temperature (°C) Salinity 
(ppt) 
TDS (mg L−1) NH3-N (mg L−1) NO2-N (mg L−1) NO3-N (mg L−1) 
Control 3.15 7.4 22.5 20.0 15.97 0.80 0.025 0.02 
Treatment 4.09–4.30 7.1–7.4 22.3–22.5 19.8–20.0 15.49–16.00 0.50–1.60 0.043–0.070 0.06–0.13 
DO, dissolved oxygen; TDS, total dissolved solid; NH3-N, total ammonia nitrogen; NO2-N, total nitrite nitrogen; NO3-N, total nitrate nitrogen 
  
 
0.22 μm filtered Milli-Q water was used. The washing steps 
were repeated twice to collect the cell pellets. Immediately 
after washing, 1 mL of 50 mmol L−1 EDTA (Sigma-Aldrich, 
Co., USA) was used to re-suspend the cell pellets and placed 
on ice for 5 min. After incubation, cells were collected by 
centrifugation. The re-suspension step was repeated again 
with 1 mL of 0.22 μm filtered Milli-Q water. In the final step 
of re-suspension, the cells were re-suspended using the same 
protocol by replacing Milli-Q water with 1 mL of 0.3 mol L−1 
sucrose (Systerm®, Malaysia). The lactococcal cells were 
then collected by centrifugation. 
Prior to electrotransformation, competent lactococcal cells 
were re-suspended in 0.2 mL of 0.3 mol L−1 sucrose. 
Immediately after re-suspension in sucrose, the cells were 
mixed with 2 μg of plasmid DNA. The plasmid DNA used 
in this study was pLS1GFP (KitMyGEN, Spain), a broad- 
host-range pMV158 replicon, which carries a tetL gene 
encoding a TetR determinant (Ruiz-Cruz et al. 2010), 
ermAM gene encoding an ErmR determinant (Ruiz-Masό  
et al. 2012) and the gfp gene (Fernández de Palencia et al. 
2000). Cell suspensions (100 μL) were transferred into a 
pre-chilled disposable electroporation cuvette (Bio-Rad 
Laboratories Inc., USA) (2-mm electrode gap) and subjected 
to a single pulse [2.5 kV (E = 12.4 kV cm−1), 200 Ω and 25 μF 
corresponding to pulse length of 4.6 ms] using a Gene Pulser 
(Xcell™, Bio-Rad Laboratories Inc., USA). Immediately after 
discharge, the cell suspensions were transferred to 1 mL of 
ice-cooled MRS broth (supplemented with 5 μg mL−1 eryth- 
romycin) and placed on ice for 5 min. Cell suspensions were 
incubated at 37 °C for 2 h and 100 μL was plated on MRS 
agars (supplemented with 5 μg mL−1 erythromycin) for the 
selection of erythromycin-resistant transformants. The plates 
were incubated for 4 to 5 days at 30 °C and colonies were 
inoculated onto fresh MRS agars. 
To detect gfp-transformed L. lactis in A. franciscana, 
Artemia cysts were surface-disinfected and followed by 
the hatching process as described previously (BArtemia 
Nauplii Hatching and Pre-disinfection^ section). Artemia 
nauplii were transferred to a conical flask containing 
200 mL of gfp-transformed L. lactis bacterial suspension 
(108–109 CFU mL−1) and mild aeration was provided dur- 
ing the experiment. After 6 and 12 h of bioencapsulation, 
10–15 nauplii were collected using a Pasteur pipette and 
transferred into Petri dishes containing 10 mL sterile PBS 
(PBS containing 10 g L−1 Instant Ocean® Sea Salt). The 
nauplii were observed under a fluorescence microscope 
(Olympus BX43, Olympus Co., Japan) equipped with an 
excitation Standard FITC set, a DP26 digital camera sys- 
tem and UIS2 optical components, for colonization of the 
gfp-transformed L. lactis. GFP fluorescence was detected 
by exposing the Artemia to ultraviolet light at a wave- 
length of 450–490 nm. The images were captured using     
a DP26 digital camera system. 
Statistical Analysis 
 
The data were analyzed for normality and homogeneity of 
variance. For the data in percentage values, they were trans- 
formed to a square root value prior to the analysis using 
ANOVA (Tukey test). Significant values were accepted at P 
value < 0.05. Statistical analysis was performed using the 
Statistical Package for the Social Sciences (SPSS) Version 20. 
 
 
Results 
 
Generally, Lactococcus lactis subsp. lactis CF4MRS at 
108 CFU mL−1 and bioencapsulated for 8 h to Artemia 
franciscana nauplii showed the highest protective effect 
against Edwardsiella sp. infection. The survival of both 
A. franciscana groups in the negative control and those ad- 
ministrated with 106 CFU mL−1 L. lactis showed a similar 
trend with no significant differences (P > 0.05) found between 
the blank treatment and positive control (Fig. 1a). Application 
of different L. lactis cell densities resulted in a slight increase 
in the relative percentage of survival (RPS) compared to the 
positive control (Table 2). No significant difference was found 
in the survival of A. franciscana in the negative and blank 
treatments (P > 0.05) (Fig. 2a). However, all L. lactis densities 
(106–109 CFU mL−1) showed a significant reduction (P 
< 0.05) in the survival rate of A. franciscana (Fig. 2a) re- 
gardless of the bioencapsulation duration, when compared to 
the positive control. A  lower  survival  was noticed   when 
A. franciscana administrated with 106 CFU mL−1 L. lactis 
for 4 h (Fig. 1b). However, no significant difference was ob- 
served in the survival of A. franciscana administrated with 
107–109 CFU mL−1 L. lactis (P > 0.05) (Fig. 2a). The RPS 
was recorded in the range of 31.7–48.3 within 4–12 h 
(Table 2). The survival of A. franciscana (108 CFU mL−1 
L. lactis; 8 h) was higher than those fed with 109 CFU mL−1 
L. lactis (Fig. 1c). In terms of RPS, A. franciscana adminis- 
trated with 108 CFU mL−1 L. lactis showed the highest pro- 
tective effect against Edwardsiella sp. (RPS = 50.0) (Table 2). 
Bioencapsulated Artemia with 108 CFU mL−1 L. lactis for 8-h 
duration showed 50% survival rate which was similar to those 
found in the negative control (nauplii not challenged with 
Edwardsiella sp.) (Fig. 2a). This trend, however, did not occur 
during the extended period of bioencapsulation (t = 12 and 
24 h). The survival did not significantly differ (P > 0.05) in 
the A. franciscana treated with different L. lactis cell densities. 
In terms of bioencapsulation time, no significant difference 
(P > 0.05) was observed among the duration and cell density, 
except for the negative and blank treatments (Fig. 2b). 
The total estimated bacteria bioencapsulated in the 
A. franciscana increased relatively to the bacterial density and 
bioencapsulation time (Fig. 3). Only a cell density at 
109 CFU mL−1 showed a significant difference (P > 0.05) 
  
 
 
Fig. 1 Survival of A. franciscana administrated with or without L. lactis 
for a 1 h, b 4 h, c 8 h, d 12 h, and e 24 h in the presence of Edwardsiella 
sp. (in vivo challenging) or without Edwardsiella sp. positive 
control, negative  control,   blank control,  nauplii 
administered  with  106 CFU  mL−1,    107 CFU mL−1, 
108 CFU mL−1, and 109 CFU mL−1 of L. lactis. Vertical error 
bars indicate standard deviation of means 
 
compared to the lower bacterial densities and the control (with- 
out bioencapsulation). The total number of bacteria in the 
A. franciscana increased tenfold when compared to those in 
the control (1.7 × 106 CFU mL−1), resulting in an average of 
5.2 × 106 CFU mL−1 of bacteria when administrated with 
109 CFU mL−1 of L. lactis in the first hour. The total estimated 
  
 
Table 2 Mortality and relative percentage survival (RPS) of L. lactis subsp. lactis-bioencapsulated A. franciscana after challenged with Edwardsiella 
sp. 
Lactococcus lactis subsp. lactis CF4MRS concentration 
 
 
Controla 
  
106 CFU mL−1 
  
107 CFU mL−1 
  
108 CFU mL−1 
  
109 CFU mL−1 
 
Time (h) Mortality (%) RPS 
 
Mortality (%) RPS 
 
Mortality (%) RPS 
 
Mortality (%) RPS 
 
Mortality (%) RPS 
1 100 – 
 
97 3.3 
 
65 35.0 
 
77 23.3 
 
77 23.3 
4 100 –  68 31.7  52 48.3  52 48.3  53 46.7 
8 100 –  60 40.0  68 31.7  50 50.0  80 20.0 
12 100 –  52 48.3  58 41.7  58 41.7  63 36.7 
24 100 –  73 26.7  70 30.0  73 26.7  72 28.3 
a 
Artemia did not receive administration of Lactococcus lactis subsp. lactis and are challenged with Edwardsiella sp. 
 
 
 
 
Fig. 2 Survival of A. franciscana 
at the end of experiment (5 days). 
a Survival rate at different 
bioencapsulation durations. b 
Survival rate at different 
treatments. Mean values with 
same letters within groups are not 
significantly different (HSD0.05). 
Vertical bars indicate standard 
deviation of means 
L. lactis L. lactis L. lactis 
L. lactis 
Treatment 
  
 
Fig. 3 Estimation of total bacteria 
bioencapsulated in A. franciscana 
at 1, 4, 8, 12, and 24 h, introduced 
by the initial cell densities of 
L. lactococcus subsp. lactis at 
106, 107, 108, and 109 CFU mL−1. 
Mean values with same letters 
within groups are not 
significantly different (HSD0.05). 
Vertical bars indicate standard 
deviation of means 
 
 
 
 
 
 
 
 
 
 
count of bacteria also increased tenfold when exposed to 108 and 
109 CFU mL−1 of L. lactis (3.2 and 5.1 × 108 CFU mL−1, re- 
spectively) for 4 h while the bacterial count in the control was 
only 1.4 × 107 CFU mL−1. When the bioencapsulation time was 
extended to 8 h, a remarkable change was observed, whereby the 
total bacterial count increased to 20-fold at 108 (2.4 × 108) and 
109 CFU mL−1 (3.9 × 108 CFU mL−1) L. lactis, respectively. The 
total bacterial count continued to increase up to 40-fold com- 
pared to the control when the time was extended to 12 and 24 h. 
In terms of bacterial uptake, proliferation and colonization, 
control Artemia did not have a fluorescent signal after ultra- 
violet light exposure (Fig. 4a, b). In contrast, green fluorescent 
spots were detected on the external trunk surfaces, including a 
pair of locomotion antennules of the instar after being admin- 
istered with gfp-transformed L. lactis for 6 h. The fluorescence 
intensity was particularly intense in the areas of the esophagus 
up to the mid-gut (Fig. 4c), suggesting that the bacterial intake 
could have commenced at the stages of instar II to III. 
 
 
 
Fig. 4  Visualization of  gfp-transformed  L.  lactic subsp. lactis in 
A. franciscana: a  wild-type A. franciscana without  administrated  to 
L. lactis (control) under bright-field-view microscopy; b wild-type control 
A.  franciscana under dark-field-view microcopy; c  instar  II  of 
A. franciscana administrated to 108–109 CFU mL−1  gfp-transformed 
L. lactic for 6 h; d nauplii of A. franciscana administrated to the same 
concentration of gfp-transformed L. lactic for 12 h. Putative adhesion of 
bacteria (c, d) in the mid-gut (indicated with arrows) and hindgut areas 
(arrow heads) were viewed under dark-field-view microcopy with expo- 
sure of ultraviolet light in the range of 450–490 nm 
L. lactis L. lactis L. lactis 
L. lactis L. lactis 
  
 
Bacterial proliferation in gut epithelial cells was observed in 
the nauplii (12 h). Bacterial cells were mostly confined to the 
GI tract and colonized mainly to the anterior parts of the body 
surface (Fig. 4d). In comparison with instar, the bacteria in the 
nauplii colonized the entire digestive tract towards the 
hindgut. 
 
 
Discussion 
 
In this present study, Artemia franciscana administrated with 
Lactococcus lactic subsp. lactis CF4MRS showed a signifi- 
cant survivorship after challenged with Edwardsiella sp. RPS 
showed A. franciscana administrated with 108 CFU mL−1 for 
8-h bioencapsulation offered the best protection against 
Edwardsiella sp. (Table 2). However, the cell density of 
L. lactis in the range of 106–109 CFU mL−1 shared the same 
protection as the survival of A. franciscana in the pathogenic 
challenging de facto. This result is in agreement with Touraki 
et al. (2013) where the authors found no significant effect on 
the survival of A. franciscana regardless of the dosage con- 
centration of L. lactis subsp. lactis used in Vibrio anguillarum 
challenge study. And yet, some studies suggest that a probiotic 
concentration of at least 108 CFU mL−1 is required to protect 
Artemia from Vibrio spp. infection (Lamari et al. 2013). When 
L. lactis is used as a prophylactic treatment for sea bass to 
prevent against vibriosis infection, the application dosage 
of the probiotic is suggested to be within the range of 106–
107 CFU mL−1 (Touraki et al. 2013). There are nu- merous 
studies on the application of lactic acid bacteria in fish and 
shrimp cultures; all of these showed promising results in 
disease protection. However, it is worth men- tioning that 
when L. lactis was supplied solely in live feed cultivation 
(Artemia in our case), without a pathogen, a noticeable 
mortality rate of Artemia was observed in the culture (Figs. 
1 and 2); this is presumably attributed to starvation as no 
food was provided during the bioencapsulation process. 
The administration of the probiotic before the first exog- 
enous feeding can facilitate the establishment of beneficial 
bacteria through their colonization in the digestive tract 
(Motlagh et al. 2012). Bacterial colonization in the digestive 
tract relies mainly on the number of bacteria being intro- 
duced and its proliferation capability in the intestinal system 
(Ziaei-Nejad et al. 2006). Therefore, it is crucial to under- 
stand the effects of bacterial density and incubation time, 
and the interaction between these two factors with/without 
exposure to the pathogen. The total bacterial count 
entrapped in A. franciscana exposed to L. lactis at 108– 
109 CFU mL−1 showed a significant increment at prolonged 
bioencapsulation duration i.e. > 4 h. Although Artemia 
cysts were surface-sterilized with povidone-iodine 
(Ovadine®), some bacteria were still observable on the 
surface of A. franciscana in the control group. This presum- 
ably could be due to the presence of natural microflora in the 
hatched nauplii. According to Sahul Hameed (1993) and 
Phatarpekar et al. (2002), the crustacean Penaeus indicus 
and Macrobrachium rosenbergii larvae were found to be 
dominated by some bacteria species upon hatching, even 
though their egg homogenates were sterile (Colorni 1985). 
This might be primarily due to the natural microflora pres- 
ent in the digestive tract of the animals (Colorni 1985). Our 
results indicate that bioencapsulation using L. lactis at 108– 
109 CFU mL−1 could improve the total bacterial count in 
A. franciscana from 10- to 40-fold compared to those in the 
control. The recovery of the probiotic was relatively higher 
than that of  other strains such as  Bacillus  subtilis and 
B. licheniformis, where only 104–106 CFU mL−1 of the total 
bacterial count were recovered from bioencapsulated 
A. urmiana (Motlagh et al. 2012). The higher CFU mL−1 
presented in this study could be due to different probiotic 
strains, Artemia species and also the enumeration technique 
used as well. 
In terms of bacterial uptake, proliferation and coloniza- 
tion, results showed that L. lactis mainly localized at the 
external trunk surfaces and in the digestive tracts of the zoo- 
plankton (Artemia nauplii). Probiotic adhesion capacity on 
the intestinal tract is a fundamental prerequisite in probiotic 
treatments to transient colonization, while others include an- 
tagonistic activity against invasive pathogens and the stimu- 
lation of innate immunity (Lauzon et al. 2008; Fjellheim et al. 
2010; Motlagh et al. 2012). The adhesion capacity of a puta- 
tive probiotic can be assessed through different approaches 
such as a cell line attachment assay. Lauzon et al. (2008) 
showed that the adhesion capacity of an actinobacteria group 
of probiotic which was isolated from salmon was only prom- 
inent in certain cell lines. Lactic acid-producing bacteria, 
especially Carnobacterium divergens V41, do not adhere 
to Epithelioma papulosum cyprini (EPC) cell lines. The au- 
thors suggested that the evaluation of adhesion capacity sole- 
ly based on cell lines could be a limitation. Furthermore, no 
cell line has yet been established for freshwater fish (Lauzon 
et al. 2008). Our study showed that the gfp-transformed 
L. lactis subsp. lactis has shown a significant capability of 
proliferation and colonization of the probiotic. More impor- 
tantly, it provides a real-time observation for the presence of 
bacteria on the surfaces and in the digestive tract of 
A. franciscana. To our knowledge, this is the first report on 
gut colonization and proliferation in the GI of Artemia 
through the employment of gfp. 
In conclusion, our study suggests that bioencapsulated 
Artemia with L. lactis subsp. lactis CF4MRS at 108 CFU mL−1 
for 8 h could effectively increase the survival rate of live feed up 
to 50% against Edwardsiella sp. infection. Extensive coloniza- 
tion of this bacterium on Artemia also confirms the potential use 
of this probiotic in larviculture. 
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